At a glance
ClinicalIndex Comparison RecordN/ACompleted· 32 enrolled
Drug / intervention
Heparin +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Coronary ARteriogenesis With Combined Heparin and EXercise Therapy in Chronic Refractory Angina
In Brief
A clinical study evaluating Physical rehabilitation, Heparin, and 1 other intervention for Refractory Angina and Chronic Stable Angina. Completed, enrolled 32 participants across 1 site.
Detailed Summary
This study evaluates the addition of heparin to a 2-week cycle of physical rehabilitation in the treatment of refractory angina. Half of the patients will undergo heparin-primed physical rehabilitation, while the other half will undergo only physical rehabilitation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRefractory Angina, Chronic Stable Angina
CountriesSerbia
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2013
First PostedNov 2017
Primary CompletionDec 2019
TodayJul 2026
First PostedNov 22, 2017
Enrollment StartFeb 1, 2013
Primary CompletionDec 31, 2019
TodayJul 2, 2026
Enrollment to primary: 6.9 yearsPosted 8.6 years ago
Interventions
Physical rehabilitationother
Standard treadmill exercise session
Heparindrug
Heparin i.v.
Placeboother
Sodium Chloride 0.9% i.v.